Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449256 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449268 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449241 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL6027614 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449225 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449230 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449226 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449253 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL21385113 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 | |
| SCHEMBL29449258 | 1.00 | TSHR (0.44) | TSHRTHRBEPHX1DNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745630-A1 | LIGHT-TRANSMITTING ARTICLE AND METHOD FOR IMPROVING ALKALI RESISTANCE OF LIGHT-TRANSMITTING ARTICLE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-20260092183-A1 | SURFACE LAYER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-02 | — | — | US | disclosed |
| WO-2025013661-A1 | LIGHT-TRANSMITTING ARTICLE AND METHOD FOR IMPROVING ALKALI RESISTANCE OF LIGHT-TRANSMITTING ARTICLE | 信越化学工業株式会社 | 2025-01-16 | — | — | WO | disclosed |
| US-11282709-B2 | Chemical agent for forming water repellent protective film and surface treatment method for wafers | CENTRAL GLASS COMPANY, LIMITED (JP) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092183-A1 | SURFACE LAYER | EPCAM, ICAM1, ADGRE5 | TSHR 2454/4885THRB 3650/4885EPHX1 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.